Pharmaceutical, Biotech and other research sponsors can now connect their clinical studies to longitudinal real-world data – speeding up drug development and aligning with the 21st Century Cures Act.
BIO-CAT, Inc., a biotechnology company that specializes in enzymes and other advanced microbial solutions, plans to add at least 30,000 square feet to its fermentation facilities in Zion Crossroads.
Earlier this fall, Contraline moved its operations from the University of Virginia School of Medicine into its new headquarters in Charlottesville, called “ContraLab.” ContraLab is a 2200 sq. ft. office and laboratory...